Triducive®

A new Delphi Consensus study was recently published that will help support better outcomes for multiple myeloma patients in the UK 🚀 The persistent challenge of treating relapsing multiple myeloma (MM), an incurable blood cancer, limits options as patients become refractory to multiple therapies. B-cell maturation antigen (BCMA) bispecific antibodies (BsAbs) offer a promising treatment for these patients. Triducive worked with our client and their customers using the Delphi method to establish how to effectively implement B-cell maturation antigen (BCMA) bispecific antibodies (BsAbs) within the NHS. Publication in eJHaem marks an important step forward and we anticipate continued progress with the treatment of this disease. Ian Walker Tim Warren #DelphiMethod #MultipleMyeloma #MedicalTreatments #MedicalPublication

Een nieuwe stap, met nieuwe collega’s de toekomst in

Gratitude. This week we (Baszucki Group and Metabolic Mind) hosted 50 members of our community to discuss the state of the science in ketogenic therapies for serious mental illness. The amount of work that this community has done this year is remarkable. And perhaps most exciting is that we focused on what we can DO in the coming years to translate the ongoing science into clinical implementation. Our team pictured here is the definition of a Dream Team. I am overwhelmed with gratitude for my colleagues in this work. You are family to me, and I cannot wait for all we have ahead of us! Let's turn all this rigorous science into impact for those living with mental illness! But first... I'm spending the afternoon at the spa to recover. #metabolicpsychiatry #metpsy #research #mentalhealth

Help shape the future of treatment for WM, by taking part in the WM-VOICE study. This first-of-its-kind research study is asking patients from the UK, US, Australia, Canada and the Netherlands to share their views on treatment preferences. The study has been informed by WM experts and patients, and WMUK and members of our Patient Advisory Group consulted on it, to feed in our collective experience here in the UK. The hope is that the results of this survey will help doctors to better tailor treatments to individuals, as well as inform clinical trials and research into specific treatments. More info: https://bit.ly/3UmX2b3

HF Guideline Forum 2024 Great discussions with diverse opinions at the table. Most important is the acknowledgement that we need global guidelines, that are broadly applicable. More than 70% of all people living with HF are outside of Europe and North America. Translational Medicine Academy (TMA) Dr Kishan Rees Lucas Hofmeister, PhD Andrew J. Sauer, MD Shelley Zieroth Dr. Andrea Glasauer

LEO Pharma is proud to launch Talk to the Hand, a disease awareness campaign for healthcare providers that highlights the risk factors, symptoms, and physical and emotional impact of chronic hand eczema (CHE). Learn more at https://brnw.ch/21wO09s and https://brnw.ch/21wO09p

Our managing partner, Tim Warren, recently contributed to a Delphi Consensus organised by the International Society for Medical Publication Professionals (ISMPP), aiming to establish specific guidelines for reporting consensus techniques. Given the prevalence of #consensus studies in published literature - there were 34,428 ‘consensus’ studies on PubMed in 2022-23 compared to 8,415 randomized controlled trials (RCTs) in the same period - there was an urgent need to standardize the reporting of such studies. Accurate reporting is crucial to demonstrate the legitimacy of a consensus study and enhances the likelihood of acceptance by peer-reviewers. #ACCORD stands as the first reporting guideline applicable to all consensus-based studies, offering authors a comprehensive checklist to enhance the completeness and transparency of their reporting. It is an indispensable tool for any medical writer engaged in reporting evidence derived from expert opinion. Members of the European Medical Writers Association (EMWA) can access their webinar titled "Using the ACCORD Guideline to Report Consensus Research" and learn more about the intricacies of the different consensus methods. With a decade of expertise in generating Delphi consensus for #Pharmaceutical and #Medical teams, Triducive is excited to witness and contribute to the growing interest in consensus and to be able to help advance the industry. Download the checklist now and elevate the quality of your consensus reporting (link in comments)👇

https://lnkd.in/e3uR7p8D National conversation to shape NHS 10 Year Plan Statement from Mark Flannagan, Chief Executive of Genetic Alliance UK Mark Flannagan, Chief Executive of Genetic Alliance UK, said:  “This is an opportunity to ensure that NHS reform is informed by the experiences of over 3.5 million people affected by genetic, rare and undiagnosed conditions, who often face significant challenges around diagnosis and access to care and treatment.  “We urge the Government to set new ambitions shaped by this national conversation to improve the lives of people affected by genetic, rare and undiagnosed conditions. Exciting innovations such as AI-driven diagnostics, genomic testing, cell and gene therapies and digital care support could improve the lives of millions of people by delivering faster diagnosis and improved access to specialist care and treatment. It is vital that the Government’s 10 Year Health Plan delivers this potential.” ENDS

So you’ve achieved #consensus. What next? While our extensive offering starts with generating expert opinion data, it doesn’t end there. What comes next is JUST as important to achieving your objectives such as: - Improving equity of access and uptake of products - Supporting national and local guidelines - Informing clinical practices - Contributing to the revision of referral pathways - Educating peers & policy makers Leveraging the insights gained from the #Delphi method, targeted and impactful communications campaigns can support meaningful change and improve patient outcomes. By combining expert #opinion with effective communication strategies, lasting positive impact on healthcare can be achieved. https://lnkd.in/eaXGdHW9 Emily Lassman

October is #BreastCancerAwareness month • Today, on #WearItPink Day, supported by Breast Cancer Now, the aim is to "help make life-changing research and support happen" • Know Your Lemons Foundation developed the #KnowYourLemons campaign to explain the signs and symptoms of breast cancer and encourage self-exams for breast health Early detection of breast cancer signs and symptoms can save lives